Increased DNA methylation was associated with SETD2 mutation, which is known to alter DNA methylation patterns (Tiedemann et al., 2016), in ccRCC and PRCC, and increased DNA methylation was similarly associated with PBRM1 mutation in PRCC. The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.